AJP - Endo Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 287: E32-E41, 2004. First published February 17, 2004; doi:10.1152/ajpendo.00539.2003
0193-1849/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/1/E32    most recent
00539.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (32)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DeRosa, M. A.
Right arrow Articles by Cryer, P. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DeRosa, M. A.
Right arrow Articles by Cryer, P. E.

Hypoglycemia and the sympathoadrenal system: neurogenic symptoms are largely the result of sympathetic neural, rather than adrenomedullary, activation

Michael A. DeRosa and Philip E. Cryer

Division of Endocrinology, Metabolism and Lipid Research, the General Clinical Research Center, and the Diabetes Research and Training Center, Washington University School of Medicine, St. Louis, Missouri 63110

Submitted 30 November 2003 ; accepted in final form 10 February 2004

The relative contributions of the sympathetic nervous system and the adrenal medullae, the two components of the sympathoadrenal system, to the manifestations of hypoglycemia are largely unknown. We tested the hypothesis that the neurogenic symptoms of hypoglycemia are largely the result of sympathetic neural activation. To do so, we quantitated neurogenic symptoms, as well as norepinephrine (NE) kinetics and selected hemodynamic changes, during hyperinsulinemic euglycemic and stepped hypoglycemic clamps in 15 healthy control subjects (Controls) and four bilaterally adrenalectomized patients (ADX). Plasma epinephrine responses to hypoglycemia were virtually absent in ADX, as expected. Neurogenic symptom scores increased to higher values during the hypoglycemic compared with the euglycemic clamps in both Controls (P < 0.0001) (e.g., final scores of 7.8 ± 1.2 vs. 3.0 ± 0.7) and ADX (P < 0.0001) (e.g., final scores of 10.8 ± 4.1 vs. 2.5 ± 1.0). Plasma NE concentrations (P < 0.0001) and systemic NE spillover (P = 0.0007) increased during the hypoglycemic compared with the euglycemic clamps in Controls but not in ADX. Similarly, heart rate increased (P = 0.0104), diastolic blood pressure decreased (P = 0.0003), and forearm blood flow increased (P < 0.0001) during the hypoglycemic compared with the euglycemic clamps in Controls but not in ADX. These data indicate that the neurogenic symptoms of hypoglycemia are largely the result of sympathetic neural, rather than adrenomedullary, activation. They also suggest that the plasma NE and hemodynamic responses to hypoglycemia are largely the result of adrenomedullary, rather that sympathetic neural, activation.

adrenal medullae; norepinephrine; sympathetic nervous system; epinephrine



Address for reprint requests and other correspondence: P. E. Cryer, Campus Box 8127, Washington Univ. School of Medicine, 660 South Euclid Ave., St. Louis, MO 63110 (E-mail: pcryer{at}wustl.edu).




This article has been cited by other articles:


Home page
DiabetesHome page
S. A. Amiel and P. E. Cryer
Attenuated Sympathoadrenal Responses, but Not Severe Hypoglycemia, During Aggressive Glycemic Therapy of Early Type 2 Diabetes
Diabetes, March 1, 2009; 58(3): 515 - 517.
[Full Text] [PDF]


Home page
DiabetesHome page
P. E. Cryer
The Barrier of Hypoglycemia in Diabetes
Diabetes, December 1, 2008; 57(12): 3169 - 3176.
[Full Text] [PDF]


Home page
DiabetesHome page
V. J. Briscoe, A. C. Ertl, D. B. Tate, S. Dawling, and S. N. Davis
Effects of a Selective Serotonin Reuptake Inhibitor, Fluoxetine, on Counterregulatory Responses to Hypoglycemia in Healthy Individuals
Diabetes, September 1, 2008; 57(9): 2453 - 2460.
[Abstract] [Full Text] [PDF]


Home page
Diabetes Spectr.Home page
B. B. Dokken
The Parodox of Glycemic Control and Cardiovascular Complications: Sorting Out the Data
Diabetes Spectr, July 1, 2008; 21(3): 150 - 152.
[Full Text] [PDF]


Home page
DiabetesHome page
P. Rossetti, F. Porcellati, N. B. Ricci, P. Candeloro, P. Cioli, G. B. Bolli, and C. G. Fanelli
Different Brain Responses to Hypoglycemia Induced by Equipotent Doses of the Long-Acting Insulin Analog Detemir and Human Regular Insulin in Humans
Diabetes, March 1, 2008; 57(3): 746 - 756.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. M. Arbelaez, W. J. Powers, T. O. Videen, J. L. Price, and P. E. Cryer
Attenuation of Counterregulatory Responses to Recurrent Hypoglycemia by Active Thalamic Inhibition: A Mechanism for Hypoglycemia-Associated Autonomic Failure
Diabetes, February 1, 2008; 57(2): 470 - 475.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. A. Sandoval, B. Gong, and S. N. Davis
Antecedent short-term central nervous system administration of estrogen and progesterone alters counterregulatory responses to hypoglycemia in conscious male rats
Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1511 - E1516.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. M. Canniff, M. S. Smith, D. B. Lacy, P. E. Williams, and M. C. Moore
Glucagon secretion and autonomic signaling during hypoglycemia in late pregnancy
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2006; 291(3): R788 - R795.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
J. Geddes, R. E. Warren, A. J. Sommerfield, V. McAulay, M. W.J. Strachan, K. V. Allen, I. J. Deary, and B. M. Frier
Absence of Sexual Dimorphism in the Symptomatic Responses to Hypoglycemia in Adults With and Without Type 1 Diabetes
Diabetes Care, July 1, 2006; 29(7): 1667 - 1669.
[Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. Jacobson, T. Ansari, and O. P. McGuinness
Counterregulatory deficits occur within 24 h of a single hypoglycemic episode in conscious, unrestrained, chronically cannulated mice
Am J Physiol Endocrinol Metab, April 1, 2006; 290(4): E678 - E684.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
O. Chan, W. Zhu, Y. Ding, R. J. McCrimmon, and R. S. Sherwin
Blockade of GABAA Receptors in the Ventromedial Hypothalamus Further Stimulates Glucagon and Sympathoadrenal but Not the Hypothalamo-Pituitary-Adrenal Response to Hypoglycemia.
Diabetes, April 1, 2006; 55(4): 1080 - 1087.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. E. Cryer
Mechanisms of Hypoglycemia-Associated Autonomic Failure and Its Component Syndromes in Diabetes
Diabetes, December 1, 2005; 54(12): 3592 - 3601.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. E. Inouye, O. Chan, J. T. Y. Yue, S. G. Matthews, and M. Vranic
Effects of diabetes and recurrent hypoglycemia on the regulation of the sympathoadrenal system and hypothalamo-pituitary-adrenal axis
Am J Physiol Endocrinol Metab, February 1, 2005; 288(2): E422 - E429.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.